<bill session="116" type="s" number="474" updated="2019-09-26T05:07:40Z">
  <state datetime="2019-02-13">REFERRED</state>
  <status>
    <introduced datetime="2019-02-13"/>
  </status>
  <introduced datetime="2019-02-13"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases.</title>
    <title type="short" as="introduced">Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019</title>
    <title type="short" as="introduced">Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019</title>
    <title type="display">Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019</title>
  </titles>
  <sponsor bioguide_id="W000779"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-02-13"/>
    <cosponsor bioguide_id="C000174" joined="2019-02-13"/>
    <cosponsor bioguide_id="C001088" joined="2019-02-13"/>
    <cosponsor bioguide_id="C001113" joined="2019-04-30"/>
    <cosponsor bioguide_id="D000622" joined="2019-02-13"/>
    <cosponsor bioguide_id="G000555" joined="2019-03-28"/>
    <cosponsor bioguide_id="K000367" joined="2019-02-13"/>
    <cosponsor bioguide_id="M000639" joined="2019-02-13"/>
    <cosponsor bioguide_id="P000595" joined="2019-09-25"/>
    <cosponsor bioguide_id="S001203" joined="2019-07-10"/>
    <cosponsor bioguide_id="S000770" joined="2019-02-13"/>
    <cosponsor bioguide_id="T000464" joined="2019-02-13"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-13">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-02-13" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Corporate finance and management"/>
    <term name="Government information and archives"/>
    <term name="Inflation and prices"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2019-02-13T05:00:00Z" status="Introduced in Senate">Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019

This bill requires manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare &amp; Medicaid Services (CMS) written justification&#160;for&#160;certain increases in drug prices. The CMS shall&#160;publish each&#160;submission, together with an&#160;easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.

A manufacturer that does not comply with the bill's requirements&#160;shall be&#160;subject to civil monetary penalties.</summary>
  <committee-reports/>
</bill>
